Status
Acquired by Lundbeck on May 8, 2014
Stock
CHTP
Headquarters:
Charlotte, NC
Description:
Chelsea Therapeutics International is a pharmaceutical company developing and commercializing therapeutics for a variety of human diseases.
Categories:
Biotechnology
Website:
http://chelseatherapeutics.com

Detailed Description

Update

Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. The Company is developing a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH), and related conditions and diseases along with its development of prescription products for multiple autoimmune disorders, including rheumatoid arthritis, psoriasis, inflammatory bowel disease and cancer. As of December 31, 2009, it was focused on its drug development resources on two clinical stage development projects: droxidopa for symptomatic NOH and other potential indications, and its portfolio of non-metabolized antifolate compounds for the treatment of rheumatoid arthritis.

Current Team (6)

Update

Past Team (5)

Update

Funding Rounds (2) - $24.5M

Update

Board Members and Advisors (9)

Update

Investors (1)

Update
  • Ficyggtwmdgziyl2exmj

    Venrock

    Venrock is a venture capital firm investing in technology and healthcare companies.

Offices/Locations (1)

Update
  • Office

    3530 Toringdon Way

    Suite 200

    Charlotte, NC 28277

    USA

Images (1)

Update
  • Sal0cltockgt3zebiikf